Using Heart Imaging to Predict Heart Problems in Breast Cancer Patients
Author Information
Author(s): Shen Hesong, Xu Qian, Tu Chunrong, Peng Yangling, Xie Yuhang, Miao Zhiming, Yang Rui, Zhang Jiuquan
Primary Institution: Chongqing University Cancer Hospital & Chongqing Cancer Institute
Hypothesis
Can a new scoring system based on left ventricular trabecular fractal dimension (LVTFD) improve risk stratification for cardiac dysfunction in breast cancer patients receiving anthracycline therapy?
Conclusion
The LVTFD-based score is a better method for predicting cardiac dysfunction risk in breast cancer patients than the existing HFA-ICOS score.
Supporting Evidence
- The LVTFD-based score outperformed the HFA-ICOS score in stratifying CTRCD risk.
- 73 out of 370 participants developed CTRCD, indicating a significant incidence rate.
- The C-indices for LVTFD-based score were significantly higher than those for HFA-ICOS score.
Takeaway
Doctors can use a special heart imaging technique to better understand which breast cancer patients might have heart problems from their treatment.
Methodology
The study used a Cox model to derive and validate a new score system based on LVTFD for risk stratification in breast cancer patients receiving anthracycline.
Potential Biases
The participant population may be skewed as all underwent cardiac magnetic resonance imaging.
Limitations
The study had a modest sample size and was conducted at a single center, which may limit the generalizability of the findings.
Participant Demographics
All participants were Asian women with breast cancer scheduled to receive anthracyclines.
Statistical Information
P-Value
p<0.001
Confidence Interval
0.834 (0.701–0.932) for derivation cohort; 0.830 (0.698–0.925) for validation cohort
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website